Dr. Paul Zarkowski, a faculty member specializing in the risks associated with benzodiazepines, discusses a groundbreaking French study revealing the complex link between these anxiety medications and suicide risk. The conversation highlights how benzodiazepines, while effective for anxiety, may inadvertently increase impulsivity and risk among vulnerable patients. Zarkowski advocates for cautious prescribing and thorough patient assessments, particularly for those undergoing significant life changes, to ensure safer treatment outcomes.